Clinical Trial Update: Vellus Hair Loss as a Marker for Peri-ocular Malignancy

View source ↗

Summary

A clinical trial investigating whether vellus hair loss can serve as a marker for peri-ocular malignancy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Cancer of the Face

Snippet

Sponsor: NHS Lothian | Conditions: Skin Cancer Face | Status: WITHDRAWN